Operating Lease, Liability in USD of ArriVent BioPharma, Inc. from Q1 2024 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
ArriVent BioPharma, Inc. quarterly Operating Lease, Liability history and change rate from Q1 2024 to Q4 2024.
  • ArriVent BioPharma, Inc. Operating Lease, Liability for the quarter ending December 31, 2024 was $176K.
Operating Lease, Liability, Quarterly (USD)

ArriVent BioPharma, Inc. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $176K Dec 31, 2024 10-K 2025-03-03
Q3 2024 $213K Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $250K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $285K Mar 31, 2024 10-Q 2024-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.